#Accrua
LightNews LightNews
longevitytech.bsky.social
Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every quarter.

Link as first comment.

#longevity #geroscience #DeepLongevity #Accrua #aging
Illustration of a blood drop with layers and a pill connected by a line.
October 12, 2026 at 9:22 AM
realfeedapp.com
Accrua by Deep Longevity uses an AI model to identify 'fast agers' via blood tests and directs them to GLP-1 treatments. The US telehealth platform is scheduled to launch in October 2026.

#BiologicalAGE #GLP1 #DeepLongevity
Accrua platform launches in the US in October 2026
Source: Longevity.Technology
realfeedapp.com
October 10, 2026 at 6:00 AM
newsen.bsky.social
Regent Pacific Launches Accrua: A New Era in Digital Health and Telehealth#USA#Hong_Kong#Regent_Pacific#Deep_Longevity#Accrua
Regent Pacific Launches Accrua: A New Era in Digital Health and Telehealth
Regent Pacific's subsidiary, Deep Longevity, is set to launch Accrua, a digital health platform targeting consumers in the US, utilizing AI in personalized healthcare.
third-news.com
September 28, 2026 at 3:29 PM
laotiantimes.com.web.brid.gy
Regent Pacific (0575.HK)’s Deep Longevity Launches Accrua™ US Consumer Digital Health and Telehealth Platform
Available Across All 50 US States, Extending Deep Longevity’s AI-Powered Ageing Science Directly to Consumers for a Second Growth Curve HONG KONG, Sept. 28, 2026 /PRNewswire/ — Regent Pacific Group Limited (“Regent Pacific” or the “Company“, together with its subsidiaries, the “Group“; stock code: 0575.HK), is pleased to announce that Deep Longevity, its AI-powered biological ageing […]
laotiantimes.com
September 29, 2026 at 5:13 AM
vickersbiostats.bsky.social
"We have completed 7 single-center randomized trials, with several more underway and accruing rapidly, with a total accrual approaching 10,000 ... Only one of these trials was externally funded". pmc.ncbi.nlm.nih.gov/articles/PMC...
Successful completion of large, low-cost randomized cancer trials at an academic cancer center: Successful completion of large, low-cost RCTs
Concerns about low accrual have long been a standard part of the discourse on cancer clinical trials, reaching even as far as the news media. Indeed, so many trials are closed before completing accrua...
pmc.ncbi.nlm.nih.gov
February 11, 2025 at 2:05 PM
epsteinweb.bsky.social
EFTA00729991.jpg
#epsteinweb #efta00729991
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA00729990 | EFTA00729991 EQUITY AND LIABILITIES A. Equity Euro '000 (31.12.2007) Euro'000 F. Subscribed capital 50,000 50,000 11 Revenue reserves 5,000 5,000 55,00(1 55,000 221 341 III. Differencefrom consolidation IV. Differencefrom currency exchange rage - 10,582 4,950 V. DeferredItemfrom other interest 111,131 98,911 Vi consolidated account result 158,241 183,823 259,011 288,025 B. Reserves Reserves for Investment subsidies 314,011 343,025 6,861 1,287 C. Accruals Provisions for pensions and similar Tax accruals Other accruals 7,336 32,263 46,991 6,617 47,578 41,262 85,590 95,457 D. Liabilities Amounts due to banks 908.673 maturity up to I year 451,816k (previous year 176,069k) maturity more then 5 years 30,891k (previous year I6,992k) 839,511 On-account payments received on orders (maturity up to I year) 1,521 Trade creditors (maturity up to I year) 175,542 Bills of exchange payable'own acceptance (maturity up to 1 year) 9 Amounts due to related companies (maturity up to I year 8,574 Amounts due to invcstee companies (maturity up to I year) 2,820 Other liabilities 161,825 - there of maturiy of up to I year 134,437k (previous year 70,212k) - there of for taxes 8.123k (previous year 8.224k) - there of social security costs 1,206k (previous year 1,375) 1,049 213,497 15 7,312 26,614 82,081 E. Prepayments and deferred charges 1.254,964 1.170,079 1,893 2,899 1.664,319 1.612,747 EFTA00729991 Epstein Web iOS app on the App Store.
May 5, 2026 at 7:50 PM
epsteinweb.bsky.social
EFTA01566723.jpg
#epsteinweb #efta01566723
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01566688 | EFTA01566723 GHISLAINE MAXWELL ACCT. For the Period 10/1/13 to 10/31/13 Price Balanced PIMCO FUNDS GLOBAL INVESTORS SERIES - GLOBAL INVESTMENT GRADE CREDIT FUND ISIN IE00B3BMD843 SEDOL B3BMD84 695421-91-7 BP Total Balanced $158,958.51 $92,027.29 $2,901.74 21.38 4,361.513 93,265.92 90,364.18 2,901.74 Quantity Value Adjusted Cost Original Cost Unrealized Gain/Loss Accrua Accoun Page 15 of 31 Consolidated Statement Page 18 EFTA01566723
March 1, 2026 at 4:37 PM
epsteinweb.bsky.social
EFTA01566345.jpg
#epsteinweb #efta01566345
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01566306 | EFTA01566345 GHISLAINE MAXWELL ACCT. nip For the Period 8/1/13 to Price Balanced PIMCO FUNDS GLOBAL INVESTORS SERIES - GLOBAL INVESTMENT GRADE CREDIT FUND ISIN IE00B3BMD843 SEDOL B3BMD84 695421-91-7 BP Total Balanced $151,065.93 $92,027.29 ($2,048.25) 20.25 4,361.513 88,315.93 90,364.18 (2,048.25) Quantity Value Adjusted Cost Original Cost Unrealized Gain/Loss Accrua Accounl Page 17 of 36 Consolidated Statement Page 20 EFTA01566345
March 1, 2026 at 4:18 PM
epsteinweb.bsky.social
EFTA01513454.jpg
#epsteinweb #efta01513454
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01513454 | EFTA01513454 sr. . 'teed, For the Period 4/1/13 to ♦/30/13 Consolidated Summary CONTINUED INVESTMENT ACCOUNT(S) YEAR-TO-DATE Portfolio Activity Account Number F iNANCJAL TRUST COMPANY INC it Summary Account Number F.N.Atc, AL TRUST COMPANY, INC. Beginning Market Value Net Contnbutionsi Withdrawals Income & Distributions 19,635.34 (19,637 91) 2.57 Taxable Income Tax-Exempt Income Other Income & Receipts Change in Investment Value Ending Market Value with Accruals 0.00 Realized Gain/Loss Short-term Long-term Unrealized Gain/Loss' 2.57 'Unrealized Gain/Loss represents data from the time of account inception to the current statement period. Consolidated Statement Page 3 J.P.Morgan Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00039412 CONFIDENTIAL SDNY_GM_00308610 EFTA01513454
February 27, 2026 at 8:08 PM
epsteinweb.bsky.social
EFTA01502217.jpg
#epsteinweb #efta01502217
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01502217 | EFTA01502217 sr. . 'teed, For the Period 11/1/12 to 11/30/12 Consolidated Summary CONTINUED INVESTMENT ACCOUNT(S) YEAR-TO-DATE Portfolio Activity Account Number Beginning Market Value Net Contnbutionsi Withdrawals THE HAZE TRUST W480540O5 19,348,770 38 Tax Summary Account Number Taxable Income Tax-Exempt Income THE HAZE TRUST VV480S4S06 1,130,804.46 79.57 Other Income & Receipts Income & Distributions Change in Investment Value Ending Market Value with Accruals 1,130,884.03 1,912,295.59 22,532,518.24 Realized Gain)Loss Short-term Long-term Unrealized Gain,Loss' (11,918.84) 213.024.87 227,895.93 'Unrealized Gain/Loss represents data from the time of account inception to the current statement period. Consolidated Statement Page 3 J.P.Morgan Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00026669 CONFIDENTIAL SDNY_GM_00295867 EFTA01502217 Epstein Web iOS app on the App Store.
February 27, 2026 at 10:26 AM
epsteinweb.bsky.social
EFTA01499784.jpg
#epsteinweb #efta01499784
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA01499784 | EFTA01499784 JAjj a r f- IIIM SOUTHERN FINANCIAL LW ACCT. For the Period 11/1/13 to 11/30/13 Account Summary Asset Allocation Beginning Market Value Ending Market Value Change In Value Estimated Current Annual Income Allocation Equity 7,597,418.19 3,146,500.00 (4,450,918.19) 11% Alternative Assets 1,848,918.88 1,585.056.38 (63.860.50) 6% Cash 8 Fixed Income Market Value 24,970,604.58 634,218,938.86 23,389,909.70 $28,121,466.08 Accruals Market Value with Accruals 248,150.15 634,483,099.80 280,303.53 328,401,789.81 (1.580,694.88) ($8,086,473.67) 34.143 38 ($8,061,330.19) 820.460.53 6820,480.63 83% 100% Asset Allocation Aftalittn AMIN &tub Cana romances Portfolio Activity Current Period Value Year-to-Date Value Beginning Market Value 34,216,939.66 0.00 Contributions 1/1.4thdrawals 8 Fees 15,877,678.00 (5,992,414.75) (6,429,424.88) Securities Transferred In 53.240.793.69 Securities Transferred Out Net Contributions/Withdrawals ($6,992,414.76) (38,97E089.29) $23,713,967.62 Income & Distributions 42,941 89 2,583,872.31 Change In Investment Value Ending Market Value (146,000.71) $28,121,488.08 1,823,636.25 $28,121,488.08 Accruals Market Value with Accruals 280 303.53 $28,401,789.81 280 303.53 $28,401,789.81 JP Morgan Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL aage Th Accca 2 of 28 Consolidated Statement Page 5 JPM-SDNY-00023591 SDNY_GM_00292789 EFTA01499784
February 27, 2026 at 8:23 AM
epsteinweb.bsky.social
EFTA01490264.jpg
#epsteinweb #efta01490264
https://epsteinweb.org
EFTA01490264 | EFTA01490264 J.P.Morgan FINANCIAL TRUST COMPANY INC ACCT. For the Period 6/1/10 to 6/30/10 Other Assets Summary Asset Categories Beginning Estimated Value Ending Estimated Value Change In Value 0.00 (6,731,159.99) (8,731,159.99) Swaps Market Value/Cost Current Penod Value Estimated Value (8,731,159.99) Current Allocation Other Assets Detail Quaintly Price Estimated Value 1.000 1.00 (48.084 73) Cost Adjusted Original Estimated Gain/Loss Accrua Is Swaps CLP SWAP - CLP NOTL 13,000,000,000 MD 3121/12 TO 3/17/10, START D 3121/11 PAY FLOAT CLP OIS ANN ACT/380 4.15% REC FIX, DEAL #253571031 WO Client SWPBDA-ZQ-8 NIA Page 17 of 52 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00012406 CONFIDENTIAL SDNY_GM_00281604 EFTA01490264
February 22, 2026 at 6:08 PM
epsteinweb.bsky.social
EFTA01489766.jpg
#epsteinweb #efta01489766
https://epsteinweb.org
EFTA01489766 | EFTA01489766 J.P.Morgan FINANCIAL TRUST COMPANY INC ACCT. For the Period 6/1/10 to 6/30/10 Other Assets Summary Asset Categories Beginning Estimated Value Ending Estimated Value Change In Value 0.00 (6,731,159.99) (8,731,159.99) Swaps Market Value/Cost Current Penod Value Estimated Value (8,731,159.99) Current Allocation Other Assets Detail Quaintly Price Estimated Value 1.000 1.00 (48.084 73) Cost Adjusted Original Estimated Gain/Loss Accrua Is Swaps CLP SWAP - CLP NOTL 13,000,000,000 MD 3121/12 TO 3/17/10, START D 3121/11 PAY FLOAT CLP OIS ANN ACT/380 4.15% REC FIX, DEAL #253571031 WO Client SWPBDA-ZQ-8 NIA Page 17 of 52 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00011886 CONFIDENTIAL SDNY_GM_00281084 EFTA01489766
February 22, 2026 at 5:44 PM
epsteinweb.bsky.social
EFTA01489715.jpg
#epsteinweb #efta01489715
https://epsteinweb.org
EFTA01489715 | EFTA01489715 J.P.Morgan FINANCIAL TRUST COMPANY INC ACCT For the Period 6/1/10 to 6/30/10 Other Assets Summary Asset Categories Beginning Estimated Value Ending Estimated Value Change In Value 0.00 (6,731,159.99) (8,731,159.99) Swaps Market Value/Cost Current Penod Value Estimated Value (6,731,159.99) Current Allocation Other Assets Detail Quaintly Price Estimated Value 1.000 1.00 (48.084.73) Cost Adjusted Original Estimated Gain/Loss Accrua Is Swaps CLP SWAP - CLP NOTL 13,000,000,000 MD 3121112 TO 3/17/10, START D 3121/11 PAY FLOAT CLP OIS ANN ACT/360 4.15% REC FIX, DEAL 9253571031 WO Client SWPBDA-ZQ-8 N/A Page 17 of 52 Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00011834 CONFIDENTIAL SDNY_GM_00281032 EFTA01489715
February 22, 2026 at 5:41 PM
epsteinweb.bsky.social
Parts 1-3/3 — EFTA01291896.jpg
#epsteinweb #efta01291896
https://epsteinweb.org
EFTA01291885 | EFTA01291896 Client Service Information Your Client Advisor: DAN DANIEL SABBA 345 PAFM AVENUE, 26Th FLOOR NEW YORK NY 10154-0003 Your Account Information Tax Lot Default Disposition Method Default Method for Mutual Funds: FIRST IN FIRST OUT Default Method for Stocks in a Dividend Reinvestm enl Flan: FIRST IN FIRST OUT Default Method for all Other Securities FIRST IN FIRST OUT Bond Amortization Elections: Am ochre premium on taxable bonds based on Constant Yield Method: Yes Accrual III arkel discount method for all other bond types: Constant Yield Method Include m arket discount in income annually: No Electronic Delivery You have not selected any account cam m unications for electronic delivery. To register and turn off paper corn m unications, log in to your account or contact your Client Advisor for m ore information. Important Information and Disclosures Pricing This section includes the net market value of the securities in your account on a settlement date basis, including short positions, at the close of the statement period. The market prices, unless otherwise noted. have been obtained from independent vendor services, which we believe to be reliable. Market prices do not constitute a bid or an offer, and may differ from the actual sale price. Securities for which a price is not available are marked "WA' arid are omitted from the Total. THE AS OF PRICE DATE ONLY APPEARS WHEN THE PRICE DATE DOES NOT EOUAL THE STATEMENT DATE. The pricing of securities on this statement may vary from their actual liquidation value. Prices shown should only be used as a general guide to portfolio value. Cash shown in this statement may not necessarily be available for investment due to unsettled transactions against your account(s). Prices for marketable securities are received horn various pricing services thought to be reliable; however, pricing services are sometimes unable to provide timely ',formation. Where pricing sources are not readly available, estimated prices may be used. Wien the updated price is received from the price provider, the updated price will be used in the release of the current month's statement Prior statements MI not be revised. You should always request a current valuation for your securities prior to making a financial decision or placing an order. Deutsche Bank proprietary investments and miscellaneous assets held by Discretionary Accounts, Trust Accounts and Custody Accounts include several categories of securities. Miscellaneous foreign assets are priced via third party sources believed to be reliable. For certain securities, including thinly-traded securities, debt securities in default, securities that do not have a valid pricing source, and certain third-party structured products, the last available pricing wit be listed. If the last price evadable for such securities is unchanged for a period of time deemed appropriate for that asset the current price will purge and NIA will be placed in the price field in the statement. The pricing of listed options takes into account the last closing price, as well as the current bid and offer prices. Estimated Annual Figures The estimated annual income (EAI) and estimated annual yield (EAt') figures are estimates and for informational purposes only. These figures are not considered to be a forecast or guarantee of future results. These figures are computed using information from providers believed to be reliable; however, no assurance can be made as to the accuracy. Since interest and dividend rates are subject to change at any time, and may be affected by current and future economic, political, and business conditions, they should not be relied on for making investment, trading, or tax decisions. These figures assume that the position quantities. interest and dividend rates, and prices remain constant. A capital gain or retum of principal may be included in the figures for certain securities, thereby overstating them. Refer to vriwr.pershing.coni/business_continuity.html for specific details as to formulas used to calculate the figures. Accrued interest represents interest earned but not yet received. Reinvestment The dollar amount of Mutual Fund distnbutions. Money Market Fund dividend income, Bank Deposit interest income, or dividends for other securities shown on your statement may have been reinvested. You wi not receive confirmation of these reinvestments. Upon written request to your financial institution, information pertaining to these transactions, including the time of execution and the name of the person from Fags& of 8 ()WAN ROL I Account hum ter SO LITI- ERN Crt CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(8) s GO paperless dam. NF IDan - TiAl_ Kilted arY Van." lir elrlyrATU) 2007 COMMUNICATIONS Mri."... Msrear. a rekrZa . •••••• OW.. ILA novae. nolic, Near al•C 111011••• SONY_GM_00049801 DB-SDNY-0012625 EFTA_001604 I 0 EFTA01291896
February 16, 2026 at 3:30 PM
marll.top
Unrelated but the winter Olympics accrua commefical really sounds like spring break anthem to me
February 15, 2026 at 12:49 AM
byteseu.bsky.social
Maven Wireless Sweden’s (STO:MAVEN) Sluggish Earnings Might Be Just The Beginning Of Its Problems

https://www.byteseu.com/517467/

The market wasn’t impressed with the soft earnings from Maven Wireless Sweden AB (Publ) (STO:MAVEN) recently. We did some further digging and think they have a few …
Maven Wireless Sweden's (STO:MAVEN) Sluggish Earnings Might Be Just The Beginning Of Its Problems
The market wasn't impressed with the soft earnings from Maven Wireless Sweden AB (Publ) (STO:MAVEN) recently. We did some further digging and think they have a few more reasons to be concerned beyond the statutory profit. Check out our latest analysis for Maven Wireless Sweden OM:MAVEN Earnings and Revenue History October 28th 2024 A Closer Look At Maven Wireless Sweden's Earnings One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. The accrual ratio subtracts the FCF from the profit for a given period, and divides the
www.byteseu.com
October 28, 2024 at 9:39 AM